Mechanism, Diagnostic and Therapeutic Novelties in Dermatology: Where Are We Going?

Ricardo Ruiz-Villaverde,Marta Cebolla-Verdugo,Alvaro Prados-Carmona,José Juan Pereyra Rodríguez,José Carlos Armario-Hita

DOI: https://doi.org/10.3390/life14101236

2024-09-28

Life

Abstract:Dermatology is one of the oldest specialties and yet one of the most innovative and constantly evolving ones, too [...]

biology

What problem does this paper attempt to address?

Innovations and Therapeutic Targets in Dermatology

Montserrat Fernández-Guarino,Andrés González-García,Asunción Ballester Martínez

DOI: https://doi.org/10.3390/ijms25158102

IF: 5.6

2024-07-25

International Journal of Molecular Sciences

Abstract:The focus of dermatology has increasingly shifted towards exploring new and innovative approaches [...]

biochemistry & molecular biology,chemistry, multidisciplinary
Atopic Dermatitis: Background, Objectives and Future Perspectives (Superresponders)

Ricardo Ruiz-Villaverde,Javier Domínguez-Cruz,Francisco J Navarro-Triviño,Manuel Galán-Gutiérrez,Jose Carlos Armario-Hita,Jose Juan Pereyra-Rodriguez

DOI: https://doi.org/10.3390/life12081192

2022-08-04

Abstract:In this Special Issue entitled Atopic Dermatitis: New Perspectives, we have tried to collect research of special interest related mainly to the incorporation of pathophysiological aspects and therapeutic novelties in this regard [...].
Dermoscopy: what's new?

Ralph Peter Braun,Margaret Oliviero,Isabel Kolm,Lars E. French,Ashfaq A. Marghoob,Harold Rabinovitz

DOI: https://doi.org/10.1016/j.clindermatol.2008.09.003

IF: 2.797

2009-01-01

Clinics in Dermatology

Abstract:Dermoscopy has been described as a useful tool for the early diagnosis of melanoma and the differential diagnosis of pigmented lesions of the skin. This has been proven by three independent meta analyses of the literature. Dermoscopy is a fast evolving field with a high number of new publications every year. Initially, the use of dermoscopy was limited to pigmented lesions, but it is used more and more in other situations. It has become an important tool for the diagnosis of nail pigmentations, hair and scalp disorders, and so forth. In this article we try to provide an update on recent trends and developments in dermoscopy.

dermatology
Editor's highlights — October, 2024

Lajos Kemény

DOI: https://doi.org/10.1111/ijd.17466

2024-09-04

International Journal of Dermatology

Abstract:Dermatology has seen significant advancements in understanding and treating complex immune‐mediated chronic inflammatory skin conditions such as psoriasis and atopic dermatitis. This editorial highlights five pivotal studies that delve into the real‐world effectiveness of biological therapies and the challenges of treating pediatric patients with overlapping dermatological conditions. These studies collectively underscore the need for continued research and treatment approaches in dermatology.

dermatology
Regenerative Medicine and Stem Cells in Dermatology

Eduardo K Moioli,Diana Bolotin,Murad Alam

DOI: https://doi.org/10.1097/DSS.0000000000001060

Abstract:Background: Clinically relevant regenerative medicine is still in its early stages of development. Difficulties in regenerating large-scale and complex structures, the lack of safety data, and the paucity of clinical trials have slowed the process of technological advance. Objective: To familiarize the clinician with techniques available in the laboratory and experimental approaches being tested clinically. In addition, a layout is discussed for how dermatologists can lead the way in bringing regenerative medicine to clinical reality. Methods: This article reviews the relevant literature on regenerative medicine for dermatological applications and discusses findings and techniques in a clinically relevant context. Results: Multiple cell-free and cell-based approaches for regenerating dermatologic tissues have been reported in the basic science and clinical literature. These are reviewed in the order of complexity. Conclusion: Incremental steps are needed to apply the principles of regenerative medicine to simple medical problems first. Such a stepwise approach would commence, for example, with creation of single-function tissues that could fill soft-tissue defects and proceed to the development of fully functional skin grafts. Likewise, cell-free approaches can build the foundation for the more technically demanding cell-based strategies that are likely necessary for achieving the ultimate goal of regenerative dermatology.
[Variants of biotechnological drugs in dermatology : Status quo and future]

Johannes Wohlrab,Adina Eichner

DOI: https://doi.org/10.1007/s00105-024-05403-x

2024-08-22

Abstract:Biotechnological drugs, so-called biopharmaceuticals, have complex structures, have special physicochemical characteristics and are subject to special regulatory laws. In addition to recombinant monoclonal antibodies, proteins and fusion proteins, a large number of biotechnological variations have been developed, of which antibody fragments, nanobodies, peptides, and antibody-drug conjugates in particular have found their way into clinical application. In addition to strategies for the treatment of oncological diseases, chronic inflammatory diseases in particular are being addressed, which are also becoming of great importance in dermatology. The advantages of biopharmaceuticals are increasingly being recognised and developed as part of special strategies for topical application. Due to the rapid development of molecular medicine, new targets for biopharmaceuticals are constantly being identified, and pharmacokinetically favourable biotechnological molecules are being created using refined methods. It can be assumed that this development will lead to even more highly innovative therapeutic and diagnostic options.
[What's new in dermatological research?]

F Aubin

DOI: https://doi.org/10.1016/S0151-9638(11)70096-5

Abstract:Dermatological research has been very active this year. Most of the numerous fields investigated involve the mechanisms of cutaneous regeneration and barrier function. A novel target of early ultraviolet-induced skin photodamage, the Syk kinase, has been recently identified. Synergistic relationship between telomere damage and cutaneous progerin production during cell senescence may also participate in the natural skin aging process. Interestingly, ultraviolet radiation induces an inhibitory effect on subcutaneous lipogenesis. Androgenetic alopecia or common baldness is not characterized by loss of hair follicle stem cells but by a defect in the conversion of hair follicle stem cells into active progenitor cells. It has been shown that the cornified envelope functions not only as a physicomechanical barrier, but also as both a biochemical line of antoxidant defense and an immunological line of defense. Like human papillomaviruses, Merckel cell polyomavirus belongs to the skin microbiome and different studies have demonstrated the protective role of epidermal resident microflora through the activation of innate immunity. Production of antimicrobial peptides and the activation of inflammasome and plasmacytoid dendritic cells are involved in the modulation of the cutaneous barrier function. Results from different studies suggest that IL-22 and IL-36 may be common mediators of both innate and adaptive immune responses. All these pathways interact not only to maintain cutaneous homeostasis and integrity (wound healing) but also to regulate autoinflammatory and autoimmune dermatoses (psoriasis, lupus, rosacea, atopic dermatitis, etc...). In addition, molecular mechanisms that regulate T helper type 2 differentiation and the retention at the site of inflammation of Th2 cells have been identified. New promising therapeutic targets for different chronic dermatosis are thus suggested. Mechanobiology and mechanotransduction are also emerging fields that investigate mechanical interactions between living cells and their environment and the conversion of mechanical cues into biochemical signals. Electronic second skin is now a current concept through bio-integrated epidermal electronics platforms used for different monitoring and stimulations of body functions.
Emerging Treatments and New Vehicle Formulations for Atopic Dermatitis

Sibel Ali,Ana Ion,Olguța Anca Orzan,Beatrice Bălăceanu-Gurău

DOI: https://doi.org/10.3390/pharmaceutics16111425

IF: 6.525

2024-11-08

Pharmaceutics

Abstract:Atopic dermatitis is one of the most common inflammatory skin diseases, with an increasing incidence among both children and adults. The recurrent nature, often with the persistence of symptoms, and the polymorphism of the response to current therapies have led to increased research in the therapeutic area dedicated to this condition. The understanding of pathophysiological pathways has contributed to the development of innovative therapies, including biological therapies, JAK inhibitors, but also emerging technologies like nanotechnology-based drug delivery systems. These innovations promise enhanced efficacy, reduced side effects, and improved patient outcomes. The ongoing exploration of novel vehicles, formulations, and natural biopolymers, along with cutting-edge therapeutic agents like tapinarof and mesenchymal stem cells, highlights the potential for an even more precise and personalized management of AD in the future. Despite these advances, challenges persist, particularly in ensuring the long-term safety, accessibility, and broader application of these therapies, necessitating continued research and development.

pharmacology & pharmacy
[What's new in dermatological treatment?]

M Viguier

DOI: https://doi.org/10.1016/S0151-9638(17)31065-7

Abstract:On a therapeutic point of view, 2017 in dermatology could be summarized in one disease, one pathway and in one number : atopic dermatitis, JAK inhibitors and 23. 2017 will be the year of the first registration of a biologic treatment in atopic dermatitis, dupilumab, with numerous other drugs currently in development. JAK inhibitors show promising results in several difficult-to-treat conditions, such as alopecia areata, vitiligo or atopic dermatitis, but still warrant confirmation in upcoming controlled trials. Monoclonal antibodies targeting IL-23 have confirmed in phase III studies their great efficacy in controlling psoriasis and will be soon available in practice, illustrating well the optimal link between bench side and bed in this emblematic inflammatory dermatological condition.
Advances in Diagnosis of Skin and Superficial Tissue Disorders—"Old and Emerging" Diagnostic Tools

Costantino Ricci

DOI: https://doi.org/10.3390/diagnostics14212414

IF: 3.6

2024-10-30

Diagnostics

Abstract:Skin and superficial tissue disorders (SSTDs) are some of the most common diseases affecting humans [...]

medicine, general & internal
Special Issue, "Molecular Advances in Skin Diseases 2.0"

Naoko Kanda

DOI: https://doi.org/10.3390/ijms25115928

IF: 5.6

2024-05-30

International Journal of Molecular Sciences

Abstract:Recently, the pathomechanisms of various skin diseases have been progressively elucidated [...]

biochemistry & molecular biology,chemistry, multidisciplinary
[Modern topical drugs-new developments in galenics and pharmacology]

Adina Eichner,Johannes Wohlrab

DOI: https://doi.org/10.1007/s00105-024-05404-w

Abstract:The importance of topically applied pharmaceuticals, especially for the treatment of dermatological diseases, is still essential. Thanks to detailed knowledge of the organisation and function of the physicochemical barrier of the skin, new galenic concepts have increasingly been developed to market maturity in recent years. Colloidal drug carrier systems in particular, but also targeted physicochemical modifications of matrices are used to optimise the cutaneous bioavailability of topically applied drugs. In addition, new molecules are increasingly becoming available for the development of these preparations or drugs known from systemic therapy are being formulated into topicals. Against this background, dermatopharmacology is also developing more and more into a highly specialised science in this area, which is producing innovative concepts for the therapy of special indications. In addition to the classic small-molecule drugs, biotechnological molecules are increasingly finding their way into application, so that a modern age of dermatopharmacology has dawned, which will open up previously unimagined possibilities for topical therapy now and in the coming years.
Progress in Topical and Transdermal Drug Delivery Research-Focus on Nanoformulations

Dominique Lunter,Victoria Klang,Adina Eichner,Sanela M Savic,Snezana Savic,Guoping Lian,Franciska Erdő

DOI: https://doi.org/10.3390/pharmaceutics16060817

IF: 6.525

2024-06-16

Pharmaceutics

Abstract:Skin is the largest organ and a multifunctional interface between the body and its environment. It acts as a barrier against cold, heat, injuries, infections, chemicals, radiations or other exogeneous factors, and it is also known as the mirror of the soul. The skin is involved in body temperature regulation by the storage of fat and water. It is an interesting tissue in regard to the local and transdermal application of active ingredients for prevention or treatment of pathological conditions. Topical and transdermal delivery is an emerging route of drug and cosmetic administration. It is beneficial for avoiding side effects and rapid metabolism. Many pharmaceutical, technological and cosmetic innovations have been described and patented recently in the field. In this review, the main features of skin morphology and physiology are presented and are being followed by the description of classical and novel nanoparticulate dermal and transdermal drug formulations. The biophysical aspects of the penetration of drugs and cosmetics into or across the dermal barrier and their investigation in diffusion chambers, skin-on-a-chip devices, high-throughput measuring systems or with advanced analytical techniques are also shown. The current knowledge about mathematical modeling of skin penetration and the future perspectives are briefly discussed in the end, all also involving nanoparticulated systems.
Regenerative Medicine Techniques: Clinical Applications in Aesthetic Procedures

Hernán Pinto

DOI: https://doi.org/10.1007/978-3-030-15458-5_1

2019-01-01

Abstract:Compared to lower vertebrates, the human body has a limited regenerative capacity. Regenerative medicine is an interdisciplinary emerging field that combines several converging technologies and requires an interdisciplinary collaboration between many scientific and medical fields. It is a novel response to the poor capacity of human organism to auto-regenerate correctly and persistently throughout its life span. Cosmetic and aesthetic regenerative medicine provide a particular response focus to the ageing problem and skin regeneration.
Revolutionizing the management of patients with atopic dermatitis: practical considerations

Filomena RussoAnna Rita GiampetruzziMaria Antonietta PillaOrnella De PitàElisa CamelaDepartment of Dermatology,IDI-IRCCS,Dermatological Research Hospital,Rome,Italy

DOI: https://doi.org/10.1080/14712598.2024.2334380

2024-03-26

Expert Opinion on Biological Therapy

Abstract:KEYWORDS: The introduction of new biological therapies and small-molecule drugs in the treatment of atopic dermatitis (AD) has brought about an era of unprecedented change in this field. Many of these novel therapies have proven to be very effective in suppressing the disease, although unfortunately none are curative [ Citation 1 ].

medicine, research & experimental,biotechnology & applied microbiology
Hospital Dermatology: Review of Research in 2022-2023

Juliana Berk-Krauss,Robert G Micheletti

DOI: https://doi.org/10.12788/cutis.0889

Cutis

Abstract:In the inpatient setting, dermatology consultants help reduce mortality, shorten length of stay, and reduce hospital readmissions. Recent research underscores the contributions of dermatology hospitalists, including phenotyping known and new severe cutaneous adverse drug reactions; showing improved progression-free and overall survival among those receiving dermatologic care for cutaneous reactions to immune checkpoint inhibitors; highlighting the role of dermatologists in reducing emergency department and hospital utilization by those with inflammatory skin diseases; and demonstrating ways in which dermatologists can effectively diagnose common and severe cutaneous diseases using asynchronous teledermatology, meeting the growing demand for inpatient dermatology services. This review covers selected highlights from the 2022-2023 inpatient dermatology literature.
[What's new in dermatological treatments?]

J-P Ortonne

DOI: https://doi.org/10.1016/S0151-9638(08)75489-9

Abstract:This article aims to identify and collect publications related to treatments in dermatology published during the last 12 months (October 2007 - October 2008). The large number of such papers leads to a choice "marked" by the author decision. Randomized clinical trials, cohorts, metaanalysis, guidelines have been selected in priority. However, non randomized studies, even informative clinical cases have been included. Overall, 26 articles have been selected concerning different aspects of therapeutics in dermatology and involving the following disorders : psoriasis, hypereosinophilic syndrome, vulvar neoplasias, melanoma, mycosis fungoides and Sezary syndrome, bullous pemphigoïd, vulvar pemphigus, pyoderma gangrenosum, hemangiomas, acne, atopic dermatitis, sclerodermatous chronic graft-vs-host disease, tuberous sclerosis complex, epidermal necrolysis, hirsutism, vitiligo.
Skin in the game: a review of single-cell and spatial transcriptomics in dermatological research

Samuel Schepps,Jonathan Xu,Henry Yang,Jenna Mandel,Jaanvi Mehta,Julianna Tolotta,Nicole Baker,Volkan Tekmen,Neda Nikbakht,Paolo Fortina,Ignacia Fuentes,Bonnie LaFleur,Raymond J. Cho,Andrew P. South

DOI: https://doi.org/10.1515/cclm-2023-1245

2024-04-26

Clinical Chemistry and Laboratory Medicine (CCLM)

Abstract:Single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics (ST) are two emerging research technologies that uniquely characterize gene expression microenvironments on a cellular or subcellular level. The skin, a clinically accessible tissue composed of diverse, essential cell populations, serves as an ideal target for these high-resolution investigative approaches. Using these tools, researchers are assembling a compendium of data and discoveries in healthy skin as well as a range of dermatologic pathophysiologies, including atopic dermatitis, psoriasis, and cutaneous malignancies. The ongoing advancement of single-cell approaches, coupled with anticipated decreases in cost with increased adoption, will reshape dermatologic research, profoundly influencing disease characterization, prognosis, and ultimately clinical practice.

medical laboratory technology
Probiotics in the Therapeutic Arsenal of Dermatologists

Vicente Navarro-López,Eva Núñez-Delegido,Beatriz Ruzafa-Costas,Pedro Sánchez-Pellicer,Juan Agüera-Santos,Laura Navarro-Moratalla

DOI: https://doi.org/10.3390/microorganisms9071513

IF: 4.5

2021-07-15

Microorganisms

Abstract:During the last years, numerous studies have described the presence of significant gut and skin dysbiosis in some dermatological diseases such as atopic dermatitis, psoriasis and acne, among others. How the skin and the gut microbiome play a role in those skin conditions is something to explore, which will shed light on understanding the origin and implication of the microbiota in their pathophysiology. Several studies provide evidence for the influence of probiotic treatments that target the modulation of the skin and intestinal microbiota in those disorders and a positive influence of orally administered probiotics on the course of these dermatosis. The pathologies in which the therapeutic role of the probiotic has been explored are mainly atopic dermatitis, psoriasis and acne. This article aims to review these three dermatological diseases, their relationship with the human microbiota and specially the effect of probiotics usage. In addition, the pathophysiology in each of them and the hypotheses about possible mechanisms of the action of probiotics will be described.
New and Emerging Biological and Oral/Topical Small-Molecule Treatments for Psoriasis

Elena Carmona-Rocha,Lluís Rusiñol,Lluís Puig

DOI: https://doi.org/10.3390/pharmaceutics16020239

IF: 6.525

2024-02-07

Pharmaceutics

Abstract:The introduction of biologic therapies has led to dramatic improvements in the management of moderate-to-severe psoriasis. Even though the efficacy and safety of the newer biologic agents are difficult to match, oral administration is considered an important advantage by many patients. Current research is focused on the development of oral therapies with improved efficacy and safety compared with available alternatives, as exemplified by deucravacitinib, the first oral allosteric Tyk2 inhibitor approved for the treatment of moderate to severe psoriasis in adults. Recent advances in our knowledge of psoriasis pathogenesis have also led to the development of targeted topical molecules, mostly focused on intracellular signaling pathways such as AhR, PDE-4, and Jak-STAT. Tapinarof (an AhR modulator) and roflumilast (a PDE-4 inhibitor) have exhibited favorable efficacy and safety outcomes and have been approved by the FDA for the topical treatment of plaque psoriasis. This revision focuses on the most recent oral and topical therapies available for psoriasis, especially those that are currently under evaluation and development for the treatment of psoriasis.

pharmacology & pharmacy

Mechanism, Diagnostic and Therapeutic Novelties in Dermatology: Where Are We Going?

Innovations and Therapeutic Targets in Dermatology

Atopic Dermatitis: Background, Objectives and Future Perspectives (Superresponders)

Dermoscopy: what's new?

Editor's highlights — October, 2024

Regenerative Medicine and Stem Cells in Dermatology

[Variants of biotechnological drugs in dermatology : Status quo and future]

[What's new in dermatological research?]

Emerging Treatments and New Vehicle Formulations for Atopic Dermatitis

[What's new in dermatological treatment?]

Advances in Diagnosis of Skin and Superficial Tissue Disorders—"Old and Emerging" Diagnostic Tools

Special Issue, "Molecular Advances in Skin Diseases 2.0"

[Modern topical drugs-new developments in galenics and pharmacology]

Progress in Topical and Transdermal Drug Delivery Research-Focus on Nanoformulations

Regenerative Medicine Techniques: Clinical Applications in Aesthetic Procedures

Revolutionizing the management of patients with atopic dermatitis: practical considerations

Hospital Dermatology: Review of Research in 2022-2023

[What's new in dermatological treatments?]

Skin in the game: a review of single-cell and spatial transcriptomics in dermatological research

Probiotics in the Therapeutic Arsenal of Dermatologists

New and Emerging Biological and Oral/Topical Small-Molecule Treatments for Psoriasis